![](/img/cover-not-exists.png)
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer
Price, T J, Bruhn, M A, Lee, C K, Hardingham, J E, Townsend, A R, Mann, K P, Simes, J, Weickhardt, A, Wrin, J W, Wilson, K, Gebski, V, Van Hazel, G, Robinson, B, Cunningham, D, Tebbutt, N CVolume:
112
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2015.37
Date:
March, 2015
File:
PDF, 333 KB
english, 2015